Sym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor Malignancies

Clinical trial NCT04641871 · COMPLETED

Trial details

NCT number: NCT04641871
Sponsor: Symphogen A/S
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Cancer Solid Tumor

Start date: 2020-10-12
Primary completion: 2024-06-03
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.